Asthma Flashcards
Asthma
Definition
Chronic inflammatory disorder of airways-Bronchospasms
Leads to recurrent episodes of wheezing, breathlessness, chest tightness, and cough
Associated with variable airflow obstruction
Usually reversible- The difference from COPD which is not
Risk Factors and Triggers
of Asthma
Related to patient (e.g., genetic factors)
Related to environment (e.g., pollen)
Male gender is a risk factor in children (but not adults).
Obesity is also a risk factor.
Asthma
Pathophysiology
Primary response is chronic inflammation from exposure to allergens or irritants.
*Leading to airway bronchoconstriction, hyperresponsiveness, and edema of airways
Inflammatory mediators cause what early-phase responses in Asthma
Vascular congestion
Edema formation
Production of thick, tenacious mucus
Bronchial muscle spasm
Thickening of airway walls
Late-phase response
in Asthma
Occurs within 4 to 6 hours after initial attack
Occurs in about 50% of patients
Can be more severe than early phase and can last for 24 hours or longer- Due to inflamamtion
If airway inflammation is not treated or does not resolve, it may lead to irreversible lung damage.
Structural changes in the bronchial wall known as remodeling
Clinical Manifestations
of Asthma
Unpredictable and variable
Expiration may be prolonged
Wheezing is unreliable to gauge severity. –Once asthma is severe you won’t hear wheezing secondary to no airflow going through.
Cough variant asthma- Non productive mostly
Classification of Asthma
Intermittent
Mild persistent
Moderate persistent
Severe persistent
Asthma Complications
Severe and life-threatening exacerbations
Respiratory rate >30/min
Pulse >120/min
PEFR is 40% at best. Peak expiratory flow rate. Want it to be >80%
Usually seen in ED or hospitalized
Life-threatening asthma
Too dyspneic to speak
Perspiring profusely- Diaphoretic
Drowsy/confused
Require hospital care and often admitted to ICU
Asthma Diagnostic Studies
Detailed history and physical exam
Peak flow monitoring- Can tell the PEFR
Pulmonary function tests- No bronchodilators for at least 6 hours prior- Will be a question
Chest x-ray
ABGs
Oximetry
Allergy testing-To help determine triggers
Blood levels of eosinophils- Patients who are genetically at risks. Higher levels indicate higher probability of developing
Sputum culture and sensitivity-R/O infection
Diagnostic Study in Asthma
Niox Mino
Hand-held point-of-care device
Measures fractional exhaled nitric oxide (FENO)
Their levels will tell you if they are asthmatic or not
Collaborative Care Asthma
GINA
Global Initiative for Asthma (GINA)
Current guidelines focus on
Assessing the severity of the disease at diagnosis and initial treatment
Monitoring periodically to achieve control of the disease
Collaborative Care Asthma
Teaching
Start at time of diagnosis.
Integrate through care.
Self-management
Tailored to needs of patient
Culturally sensitive
Desired therapeutic outcomes for Asthma Patients
Control or eliminate symptoms.
Attain normal lung function.
Restore normal activities.
Reduce or eliminate exacerbations and side effects of medications.
Collaborative Care
Intermittent and persistent asthma
Avoid triggers of acute attacks.
Pre-medicate before exercising.
Choice of drug therapy depends on symptom severity.
Respiratory distress
Treatment depends upon severity and response to therapy.
Severity measured with flow rates
Bronchodilators-short acting Albuterol for acute attack
Collaborative Care
Acute asthma exacerbations
O2 therapy may be started and monitored with pulse oximetry or ABGs in severe cases.
Short acting Brochdilators
Collaborative Care
Severe exacerbations
Most therapeutic measures are the same as for acute episode.
↑ in frequency and dose of bronchodilators